File: A dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial in Aurora, Colorado.  Michael Ciaglo / GETTY IMAGES NORTH AMERICA / AFP JOHANNESBURG - Global trials of the single-dose Johnson & Johnson vaccine shows it is 66-percent effective in protecting against COVID-19. READ: Gauteng seeing reduction in COVID-19 cases In South Africa, it was found to be 57-percent effective. Global trials of the single-dose Johnson & Johnson vaccine shows it is 66% effective in protecting against COVID-19. #eNCA Courtesy #DStv403 pic.twitter.com/sTapSqlkuy The company is looking into whether a double dose will be stronger. READ: First doses of COVID-19 vaccine to arrive on Monday This vaccine is, however, 85 percent effective in preventing severe illness and death.